Fierce Biotech

Subscribe to Fierce Biotech feed
Updated: 5 hours 32 min ago

VC firm Sofinnova banks $1B from Apollo to invest in early-stage biotech solutions

Mon, 05/16/2022 - 07:39
VC firm Sofinnova banks $1B from Apollo to invest in early-stage biotech solutions gmasson Mon, 05/16/2022 - 10:39

RadNet scores two FDA clearances for AI programs in breast, prostate cancer

Mon, 05/16/2022 - 07:09
RadNet scores two FDA clearances for AI programs in breast, prostate cancer chale Mon, 05/16/2022 - 10:09

Boston Scientific co-founder, former CEO Peter Nicholas dies at 80

Mon, 05/16/2022 - 06:58
Boston Scientific co-founder, former CEO Peter Nicholas dies at 80 apark Mon, 05/16/2022 - 09:58

New antiviral class offers hope of halting rampage of treatment-resistant viruses and beyond

Mon, 05/16/2022 - 06:49
New antiviral class offers hope of halting rampage of treatment-resistant viruses and beyond jwaldron Mon, 05/16/2022 - 09:49

AbbVie coughs up nearly $50M for Cugene's autoimmune med in a bid to shore up life post-Humira

Mon, 05/16/2022 - 06:39
AbbVie coughs up nearly $50M for Cugene's autoimmune med in a bid to shore up life post-Humira mbayer Mon, 05/16/2022 - 09:39

To TIGIT or not to TIGIT? Roche's latest trial flop casts shadow on Big Pharma's $6B bet

Mon, 05/16/2022 - 04:40
To TIGIT or not to TIGIT? Roche's latest trial flop casts shadow on Big Pharma's $6B bet jwaldron Mon, 05/16/2022 - 07:40

From Redditors to creditors: Orphazyme's wild ride ends with $13M sale to satisfy bankruptcy court

Mon, 05/16/2022 - 03:07
From Redditors to creditors: Orphazyme's wild ride ends with $13M sale to satisfy bankruptcy court ntaylor Mon, 05/16/2022 - 06:07

Shionogi splashes $100M on F2G's rare fungal disease drug to unlock new class of medicine

Mon, 05/16/2022 - 02:30
Shionogi splashes $100M on F2G's rare fungal disease drug to unlock new class of medicine ntaylor Mon, 05/16/2022 - 05:30

Kriya cashes in $270M series C to further finance all-in-one gene therapy biz

Sun, 05/15/2022 - 15:02
Kriya cashes in $270M series C to further finance all-in-one gene therapy biz mbayer Sun, 05/15/2022 - 18:02

AskBio and you shall receive as the Bayer-backed gene therapy maker touts early phase 1 data

Fri, 05/13/2022 - 13:40
AskBio and you shall receive as the Bayer-backed gene therapy maker touts early phase 1 data mbayer Fri, 05/13/2022 - 16:40

mRNA Unlocked: How Technology Convergence Is Driving the Next Wave

Fri, 05/13/2022 - 09:39
mRNA Unlocked: How Technology Convergence Is Driving the Next Wave jfrasor Fri, 05/13/2022 - 12:39

Medtronic makes FTC-mandated sale to close Intersect ENT deal, and scores FDA nod to boot

Fri, 05/13/2022 - 08:21
Medtronic makes FTC-mandated sale to close Intersect ENT deal, and scores FDA nod to boot apark Fri, 05/13/2022 - 11:21

Update: Checkmate details bleak future if $250M Regeneron merger does not close

Fri, 05/13/2022 - 08:16
Update: Checkmate details bleak future if $250M Regeneron merger does not close aarmstrong Fri, 05/13/2022 - 11:16

Researchers uncover the brain's link to SIDS, setting up potential infant screening test

Fri, 05/13/2022 - 06:38
Researchers uncover the brain's link to SIDS, setting up potential infant screening test chale Fri, 05/13/2022 - 09:38

FDA clears BD’s newest molecular diagnostics machine and its first test, a three-in-one STI screener

Fri, 05/13/2022 - 06:36
FDA clears BD’s newest molecular diagnostics machine and its first test, a three-in-one STI screener apark Fri, 05/13/2022 - 09:36

Adagio still hopes to build omicron offense for lead COVID-19 therapy

Fri, 05/13/2022 - 06:34
Adagio still hopes to build omicron offense for lead COVID-19 therapy aarmstrong Fri, 05/13/2022 - 09:34

BridgeBio adds another $110M to coffers with voucher sale a day after mega BMS deal

Fri, 05/13/2022 - 05:54
BridgeBio adds another $110M to coffers with voucher sale a day after mega BMS deal aarmstrong Fri, 05/13/2022 - 08:54

FDA tags Editas' thalassemia cell therapy an orphan drug as it rounds final bend in race to clinic

Fri, 05/13/2022 - 04:29
FDA tags Editas' thalassemia cell therapy an orphan drug as it rounds final bend in race to clinic ntaylor Fri, 05/13/2022 - 07:29

Roche's TIGIT flop prompts GSK, iTeos to reevaluate next steps for rival drug

Fri, 05/13/2022 - 01:55
Roche's TIGIT flop prompts GSK, iTeos to reevaluate next steps for rival drug ntaylor Fri, 05/13/2022 - 04:55

Healing the heart: Moderna cofounder, researchers near ‘Holy Grail’ for heart regeneration

Thu, 05/12/2022 - 15:26
Healing the heart: Moderna cofounder, researchers near ‘Holy Grail’ for heart regeneration gmasson Thu, 05/12/2022 - 18:26